Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-02-22
2005-02-22
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C260S998200, C260S998220, C530S300000
Reexamination Certificate
active
06858581
ABSTRACT:
Compositions and methods for inhibiting and controlling the growth of microbes are disclosed. The composition comprises at least one chemically-modified peptide with antimicrobial activity and at least one carrier. The method comprises of administering an amount, effective for the prevention, inhibition and termination of microbial growth for industrial, pharmaceutical, household and personal care use.
REFERENCES:
patent: 3265682 (1966-08-01), Vogler et al.
patent: 4448715 (1984-05-01), Ryan et al.
patent: 5440016 (1995-08-01), Blondelle et al.
patent: 5504190 (1996-04-01), Houghten et al.
patent: 5512549 (1996-04-01), Chen et al.
patent: 5654451 (1997-08-01), Kari
patent: 5939086 (1999-08-01), Levy
patent: 6126939 (2000-10-01), Eisenbach-Schwartz et al.
patent: 0 280 610 (1988-08-01), None
patent: 0 618 225 (1994-10-01), None
patent: 8702346 (1987-03-01), None
patent: 2020148 (1991-07-01), None
patent: 1 237 918 (1971-07-01), None
patent: HEI 8-176190 (1996-07-01), None
patent: 9201462 (1992-02-01), None
patent: 9519370 (1995-07-01), None
patent: 9640768 A2 (1996-12-01), None
patent: 9807745 A2 (1998-02-01), None
patent: 9914231 A2 (1999-03-01), None
patent: 9937667 (1999-07-01), None
patent: 0000214 A2 (2000-01-01), None
patent: WO 0059527 (2000-10-01), None
Dabrowska, M. et al., “Derivatives of the L-Lysine-Peptides with Antibacterial Activity”,Pol. J. Pharmacol Pharm, 1976, 28(1), 77-88, XP-008004973.
Kikumoto, R. et al.,“Thrombin Inhibitors. 2. Amide Derivatives of Nα-Substituted L-Arginine”,Journal of Medicinal Chemistry, American Chemical Society, US, 1980, 23(8), 830-836, XP 001008617.
Sugimoto, Y. et al., “Influence of Chemical Modification of N alpha-cocoyl-Larginine Ethyl Ester on its Hepatitis B Surface Antigen-Inactivating Effect”,Antimicrobial Agents and Chemotheraphy, 1980, 18(4), 525-528, XP 002203217.
Perez, L. et al., “Synthesis Aggregation and Biological Properties of a New Class of Gemini Cationic Amphiphilic Compounds from Arginine Bis(ARGS)”,Langmuir, 1996, 12(22), 5296-5301, XP-002203216.
Nakamura, H. et al., “Antibacterial Activity of Amphipathic Basic Peptides with a Long Acyl Group and Their Interaction with Phospholipid Bilayers,”Bull Chem Soc Jpn, Apr. 1, 1990, 63(4), 1180-1184.
International Search Report from corresponding PCT Application PCT/US01/19400; Date of Mailing: Oct. 2, 2002.
Falla T.J. et al., “Mode of action of the antimicrobial peptide indoicidin”,1996, vol. 271 (32), pp 19298-19303.
Hancock,R E.W.,“The therapeutic potential of cationic peptides”Exp. Opin. Invest. Drugs, 1998, 7(2), pp 167-174.
Hancock,R.E.W., et al., “Cationic bactericidal peptides”Advances In Microbial Physiology, 195, vol. 37, pp 135-175.
Hancock,R.E.W. et al., “Cationic peptides: a new source of antibiotics”TiB Tech., 1998, 16, pp82-88.
Lehrer et al.,“Defensins: Natural peptide antibiotics from neutrophils”ASM News, 1990, 56, 315-318.
Merrifield,R.B.,“Solid phase peptide synthesis. I. The synthesis of a tetrapeptide”J. Amer. Chem Soc., 1963, 85, pp 2149-2154.
Nguyen-Dinh P., et al.,“Antiparasitic agents and suceptibility tests”Manual of Clinical Microbiology, 7thEdition, pp 1653-1662.
Oh et al.,“Structure-activity relationship study:short antimicrobial peptides”J. Peptide Res., 1998, 56, pp 41-46.
Wakabayashi et al.,“N-acylated and d enantiomer derivatives of a nonamer core peptide of lactoferricin b showing improved antimicrobial activity”Antimicrobial Agents and Chemotherapy, 1999, 43, 1267-1269.
“A formulary of cosmetic preparations” vol. 2, Chapters 7-16, pp 5-484.
Goodman & Gilman's:The Pharmacological Basis of Therapeutics(8thedition), pp 1-83.
Gutte B., “Peptides: Synthesis, Structures and Applications” 1995.
Lloyd-Williams et al., “Chemical approaches to the synthesis of peptides and proteins”1997.
Remington's Pharmaceutical Sciences (part 8), pp 1435-1694.
The CFTA Cosmetic Ingredient Handbook, 1992, 2ndedition.
Kuhner Carla H.
Romesser James A.
Arizona State University
Christine, Meis, McAuliffle, Esq.
Jennings Strouss and Salmon, PLC
Navarro Mark
LandOfFree
Chemically-modified peptides, compositions, and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemically-modified peptides, compositions, and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemically-modified peptides, compositions, and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3447066